Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.21.2
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted
Stock Units		  
    Number of
shares
subject to
warrants		     Weighted-average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		  
Balance at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053  
Granted     90,461       4.00      
—  
      
—  
       540,507  
Exercised    
—  
      
—  
      
—  
      
—  
       (368,921 )
Expired    
—  
      
—  
      
—  
      
—  
       (129,166 )
Balance at June 30, 2021     762,920     $ 7.60       118,388     $ 3.25       2,343,473  
Exercisable at June 30, 2021     762,920     $ 7.60       118,388     $ 3.25       1,283,612  

 
Schedule of fair value of the warrants as of original issuance date
    Issuance date  
Risk-free interest rate     0.49 %
Expected dividend yield    
-
 %
Expected volatility     100 %
Term      5 years  
Fair value of common stock   $ 1.95  

 
Schedule of company’s outstanding warrants and options
Warrants Outstanding   Warrants Exercisable  
Exercise Price Range   Number Outstanding     Weighted Average
Remaining
Contractual Life (in
years)		     Weighted Average
Exercise Price		     Number
Exercisable		     Weighted Average
Exercise Price		     Intrinsic Value  
$ 3.80 - $141.17     762,920       2.96     $ 7.60       762,920     $ 7.60      
-
  

 

Options Outstanding   Options Exercisable  
Exercise Price Range   Number Outstanding     Weighted Average
Remaining
Contractual Life (in
years)		     Weighted Average
Exercise Price		     Number
Exercisable		     Weighted Average
Exercise Price		     Intrinsic Value  
$ 2.64 - $28.50     118,388       3.19     $ 3.25       118,388     $ 3.25      
-
  

 
Schedule of stock-based compensation expense
    For the three months ended     For the Six months ended  
    June 30,     June 30,  
    2021     2020     2021     2020  
Stock-based compensation expense   $ 729,644     $ 1,988,883     $ 1,230,362     $ 2,356,547  

 
Schedule of stock-based compensation expense categorized by the equity components
    For the three months ended     For the Six months ended  
    June 30,     June 30,  
    2021     2020     2021     2020  
Common stock   $ 729,644     $ 1,988,883     $ 1,230,362     $ 2,356,547  
Total   $ 729,644     $ 1,988,883     $ 1,230,362     $ 2,356,547